adplus-dvertising
Connect with us

News

PM touts deal for 26K doses of COVID-19 therapeutic, seeks to temper vaccine expectations – CTV News

Published

 on


OTTAWA —
Prime Minister Justin Trudeau has announced that the federal government has signed a deal to secure up to 26,000 doses of a COVID-19 therapeutic drug from Eli Lilly, with the option to receive thousands more.

He also sought to temper Canadians’ expectations around the timing and rollout of an eventual vaccine or vaccines to immunize against the novel coronavirus.

“To keep Canadians safe, we need access to as many potential vaccines and treatments as possible,” Trudeau said during his Rideau Cottage address on Tuesday.

Trudeau said that, while there has been promising news about some vaccine candidates that Canada will receive millions of doses of, it will still be months before vaccines are expected to arrive on Canadian soil.

The prime minister has previously said that Canada is expecting initial doses — to be distributed on a priority basis — in the early months of 2021 once granted approval by Health Canada, but several other nations are making plans to begin administering vaccines next month.

Among the promising candidates so far are Pfizer, Moderna, and AstraZeneca, all of which Canada has begun the domestic approval process for. However, Trudeau said that because it’s been years since Canada’s had domestic production capacity for vaccines, the countries where these pharmaceutical companies are based will “obviously” prioritize vaccinating their citizens before shipping doses internationally.

As a result, the federal government is working with the dates vaccine companies are providing them.

“We have reached out and have actually one of the very best vaccine portfolios of any country around the world with far more doses for Canadians, potentially then we actually have Canadian population. That’s because we don’t know which vaccines are going to be most effective, which ones are going to arrive early, but we have done everything we can to ensure that Canadians get these vaccines as quickly as possible,” Trudeau said, acknowledging Canada is at a “disadvantage,” because it is relying on other nations.

“But it is premature to start, you know, crossing out [or] circling dates on a calendar or saying that ‘this vaccine is going to arrive in this amount, on this day, in this community,’ because there’s still a lot of work to do between now and then, but we’re on it,” he said.

The prime minister said that Canada has begun funding domestic vaccine production capacity because “we never want to be caught short again,” but it will take “years” to get in place and likely won’t help Canada’s COVID-19 vaccine situation, but will be in place should there be future pandemics.

Updating on the status of the logistical planning, Procurement Minister Anita Anand said that the federal government has signed contracts for freezers capable of storing vaccines. To-date the government has the capacity to store up to 33.5 million vaccines at cold temperatures and enough needles and syringes to administer 24 million doses with more en route. By next week, Anand said she expects contracts will be awarded to provide the government with dry ice as well as end-to-end distribution to assist in the transportation of these vaccines.

The government says it’s keeping a close eye on the approval processes for vaccines in allied countries, but isn’t expected to fast-track authorization until the domestic evaluation is complete, which Trudeau said is being done to assure Canadians the vaccines are safe, in hopes that’ll encourage the maximum number of people get immunized.

Logistical planning about the rollout is underway, but details remain sparse other than the military likely playing a role and all provinces and territories needing to provide input. Trudeau said Tuesday, the federal Liberals will have more to share once the “mobilization plan” is “up and running.”

EMERGENCY THERAPY APPROVED

Over the weekend, Health Canada authorized the monoclonal antibody therapy for emergency use in helping treat COVID-19 infections, and Canada will begin receiving doses over the next three months.

The single antibody treatment called bamlanivimab has been approved for use in adults and children aged 12 or older with mild to moderate coronavirus infections.

Lilly says the treatment is for those who risk progressing to severe COVID-19 symptoms or hospitalization. It is not authorized for patients who are already hospitalized or require oxygen.

Bamlanivimab is the first monoclonal antibody to be authorized for use in treating the novel coronavirus and was granted emergency-use by the Food and Drug Administration in the U.S. at the beginning of November.

The antibody therapy, which must be infused in a hospital or other health-care setting, was developed in partnership with the Canadian biotech company AbCellera, which the federal government has provided funded to over the course of the pandemic.

“To the scientists and researchers across the country: Thank you for everything that you do. Just like always, your dedication and expertise is making Canadians heathier and safer, and is building a better tomorrow. Canada is lucky to have thousands of world-class scientists and researchers,” said Trudeau.

Health Canada granted authorization for Lilly’s antibody therapy under Section 3 of the federal government’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

With files from CTV News’ Brooklyn Neustaeter

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

News

Looking for the next mystery bestseller? This crime bookstore can solve the case

Published

 on

WINNIPEG – Some 250 coloured tacks pepper a large-scale world map among bookshelves at Whodunit Mystery Bookstore.

Estonia, Finland, Japan and even Fenwick, Ont., have pins representing places outside Winnipeg where someone has ordered a page-turner from the independent bookstore that specializes in mystery and crime fiction novels.

For 30 years, the store has been offering fans of Agatha Christie’s Hercule Poirot or Arthur Conan Doyle’s Sherlock Holmes a place to get lost in whodunits both old and new.

Jack and Wendy Bumsted bought the shop in the Crescentwood neighbourhood in 2007 from another pair of mystery lovers.

The married couple had been longtime customers of the store. Wendy Bumsted grew up reading Perry Mason novels while her husband was a historian with vast knowledge of the crime fiction genre.

At the time, Jack Bumsted was retiring from teaching at the University of Manitoba when he was looking for his next venture.

“The bookstore came up and we bought it, I think, within a week,” Wendy Bumsted said in an interview.

“It never didn’t seem like a good idea.”

In the years since the Bumsteds took ownership, the family has witnessed the decline in mail-order books, the introduction of online retailers, a relocation to a new space next to the original, a pandemic and the death of beloved co-owner Jack Bumsted in 2020.

But with all the changes that come with owning a small business, customers continue to trust their next mystery fix will come from one of the shelves at Whodunit.

Many still request to be called about books from specific authors, or want to be notified if a new book follows their favourite format. Some arrive at the shop like clockwork each week hoping to get suggestions from Wendy Bumsted or her son on the next big hit.

“She has really excellent instincts on what we should be getting and what we should be promoting,” Micheal Bumsted said of his mother.

Wendy Bumsted suggested the store stock “Thursday Murder Club,” the debut novel from British television host Richard Osman, before it became a bestseller. They ordered more copies than other bookstores in Canada knowing it had the potential to be a hit, said Michael Bumsted.

The store houses more than 18,000 new and used novels. That’s not including the boxes of books that sit in Wendy Bumsted’s tiny office, or the packages that take up space on some of the only available seating there, waiting to be added to the inventory.

Just as the genre has evolved, so has the Bumsteds’ willingness to welcome other subjects on their shelves — despite some pushback from loyal customers and initially the Bumsted patriarch.

For years, Jack Bumsted refused to sell anything outside the crime fiction genre, including his own published books. Instead, he would send potential buyers to another store, but would offer to sign the books if they came back with them.

Wendy Bumsted said that eventually changed in his later years.

Now, about 15 per cent of the store’s stock is of other genres, such as romance or children’s books.

The COVID-19 pandemic forced them to look at expanding their selection, as some customers turned to buying books through the store’s website, which is set up to allow purchasers to get anything from the publishers the Bumsteds have contracts with.

In 2019, the store sold fewer than 100 books online. That number jumped to more than 3,000 in 2020, as retailers had to deal with pandemic lockdowns.

After years of running a successful mail-order business, the store was able to quickly adapt when it had to temporarily shut its doors, said Michael Bumsted.

“We were not a store…that had to figure out how to get books to people when they weren’t here.”

He added being a community bookstore with a niche has helped the family stay in business when other retailers have struggled. Part of that has included building lasting relationships.

“Some people have put it in their wills that their books will come to us,” said Wendy Bumsted.

Some of those collections have included tips on traveling through Asia in the early 2000s or the history of Australian cricket.

Micheal Bumsted said they’ve had to learn to be patient with selling some of these more obscure titles, but eventually the time comes for them to find a new home.

“One of the great things about physical books is that they can be there for you when you are ready for them.”

This report by The Canadian Press was first published on Sept. 15, 2024.



Source link

Continue Reading

News

Labour Minister praises Air Canada, pilots union for avoiding disruptive strike

Published

 on

MONTREAL – Canada’s labour minister is praising both Air Canada and the union representing about 5,200 of its pilots for averting a work stoppage that would have disrupted travel for hundreds of thousands of passengers.

Steven MacKinnon’s comments came in a statement shared to social media shortly after Canada’s largest air carrier announced it had reached a tentative labour deal with the Air Line Pilots Association.

MacKinnon thanked both sides and federal mediators, saying the airline and its pilots approached negotiations with “seriousness and a resolve to get a deal.”

The tentative agreement averts a strike or lockout that could have begun as early as Wednesday for Air Canada and Air Canada Rouge, with flight cancellations expected before then.

The airline now says flights will continue as normal while union members vote on the tentative four-year contract.

Air Canada had called on the federal government to intervene in the dispute, but Prime Minister Justin Trudeau said Friday that would only happen if it became clear no negotiated agreement was possible.

This report from The Canadian Press was first published Sept. 15, 2024.

Companies in this story: (TSX:AC)

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

As plant-based milk becomes more popular, brands look for new ways to compete

Published

 on

When it comes to plant-based alternatives, Canadians have never had so many options — and nowhere is that choice more abundantly clear than in the milk section of the dairy aisle.

To meet growing demand, companies are investing in new products and technology to keep up with consumer tastes and differentiate themselves from all the other players on the shelf.

“The product mix has just expanded so fast,” said Liza Amlani, co-founder of the Retail Strategy Group.

She said younger generations in particular are driving growth in the plant-based market as they are consuming less dairy and meat.

Commercial sales of dairy milk have been weakening for years, according to research firm Mintel, likely in part because of the rise of plant-based alternatives — even though many Canadians still drink dairy.

The No. 1 reason people opt for plant-based milk is because they see it as healthier than dairy, said Joel Gregoire, Mintel’s associate director for food and drink.

“Plant-based milk, the one thing about it — it’s not new. It’s been around for quite some time. It’s pretty established,” said Gregoire.

Because of that, it serves as an “entry point” for many consumers interested in plant-based alternatives to animal products, he said.

Plant-based milk consumption is expected to continue growing in the coming years, according to Mintel research, with more options available than ever and more consumers opting for a diet that includes both dairy and non-dairy milk.

A 2023 report by Ernst & Young for Protein Industries Canada projected that the plant-based dairy market will reach US$51.3 billion in 2035, at a compound annual growth rate of 9.5 per cent.

Because of this growth opportunity, even well-established dairy or plant-based companies are stepping up their game.

It’s been more than three decades since Saint-Hyacinthe, Que.-based Natura first launched a line of soy beverages. Over the years, the company has rolled out new products to meet rising demand, and earlier this year launched a line of oat beverages that it says are the only ones with a stamp of approval from Celiac Canada.

Competition is tough, said owner and founder Nick Feldman — especially from large American brands, which have the money to ensure their products hit shelves across the country.

Natura has kept growing, though, with a focus on using organic ingredients and localized production from raw materials.

“We’re maybe not appealing to the mass market, but we’re appealing to the natural consumer, to the organic consumer,” Feldman said.

Amlani said brands are increasingly advertising the simplicity of their ingredient lists. She’s also noticing more companies offering different kinds of products, such as coffee creamers.

Companies are also looking to stand out through eye-catching packaging and marketing, added Amlani, and by competing on price.

Besides all the companies competing for shelf space, there are many different kinds of plant-based milk consumers can choose from, such as almond, soy, oat, rice, hazelnut, macadamia, pea, coconut and hemp.

However, one alternative in particular has enjoyed a recent, rapid ascendance in popularity.

“I would say oat is the big up-and-coming product,” said Feldman.

Mintel’s report found the share of Canadians who say they buy oat milk has quadrupled between 2019 and 2023 (though almond is still the most popular).

“There seems to be a very nice marriage of coffee and oat milk,” said Feldman. “The flavour combination is excellent, better than any other non-dairy alternative.”

The beverage’s surge in popularity in cafés is a big part of why it’s ascending so quickly, said Gregoire — its texture and ability to froth makes it a good alternative for lattes and cappuccinos.

It’s also a good example of companies making a strong “use case” for yet another new entrant in a competitive market, he said.

Amid the long-standing brands and new entrants, there’s another — perhaps unexpected — group of players that has been increasingly investing in plant-based milk alternatives: dairy companies.

For example, Danone has owned the Silk and So Delicious brands since an acquisition in 2014, and long-standing U.S. dairy company HP Hood LLC launched Planet Oat in 2018.

Lactalis Canada also recently converted its facility in Sudbury, Ont., to manufacture its new plant-based Enjoy! brand, with beverages made from oats, almonds and hazelnuts.

“As an organization, we obviously follow consumer trends, and have seen the amount of interest in plant-based products, particularly fluid beverages,” said Mark Taylor, president and CEO of Lactalis Canada, whose parent company Lactalis is the largest dairy products company in the world.

The facility was a milk processing plant for six decades, until Lactalis Canada began renovating it in 2022. It now manufactures not only the new brand, but also the company’s existing Sensational Soy brand, and is the company’s first dedicated plant-based facility.

“We’re predominantly a dairy company, and we’ll always predominantly be a dairy company, but we see these products as complementary,” said Taylor.

It makes sense that major dairy companies want to get in on plant-based milk, said Gregoire. The dairy business is large — a “cash cow,” if you will — but not really growing, while plant-based products are seeing a boom.

“If I’m looking for avenues of growth, I don’t want to be left behind,” he said.

Gregoire said there’s a potential for consumers to get confused with so many options, which is why it’s so important for brands to find a way to differentiate themselves, whether it’s with taste, health, or how well the drink froths for a latte.

Competition in a more crowded market is challenging, but Taylor believes it results in better products for consumers.

“It keeps you sharp, and it forces you to be really good at what you’re doing. It drives innovation,” he said.

This report by The Canadian Press was first published Sept. 15, 2024.



Source link

Continue Reading

Trending